Coral Gables, FL — November 20, 2025 — Leads & Copy — Compass Pathways plc (Nasdaq: CMPS), a biotechnology company focused on accelerating patient access to evidence-based innovation in mental health, will participate in investor conferences in December.
Management is scheduled for a fireside chat at the 8th Annual Evercore Healthcare Conference in Coral Gables, FL, at 10:00 a.m. ET on December 2, 2025. The company will also have a fireside chat at the Piper Sandler 37th Annual Healthcare Conference in New York, NY, at 1:30 p.m. ET on December 3, 2025.
Live audio webcasts of these events will be accessible from the “Events” page of the Investors section of the Compass website, with replays available for 30 days following each event.
Compass Pathways plc (Nasdaq: CMPS) is dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. Compass is pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 synthetic psilocybin treatment, potentially a first in class treatment. COMP360 has Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD).
Compass is headquartered in London, UK, with offices in New York in the US. The company envisions a world where mental health means not just the absence of illness but the ability to thrive.
Contact:
Source: Compass Pathways
